QuidelOrtho Corp QDEL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences
-
QuidelOrtho Reports First Quarter 2026 Financial Results
-
QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics
-
QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance
-
Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
Trading Information
- Previous Close Price
- $14.09
- Day Range
- $13.84–14.52
- 52-Week Range
- $9.92–35.58
- Bid/Ask
- $13.64 / $14.60
- Shares Outstanding
- 68.19M
- Market Cap
- $963.54M
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 10.52
- Price/Sales
- 0.36
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 6,500
- Website
- https://www.quidelortho.com
Valuation
|
Metric
|
QDEL
|
|---|---|
Price/Earnings (Normalized) | 10.52 |
Price/Book Value | 0.52 |
Price/Sales | 0.36 |
Price/Cash Flow | 6.18 |
Price/Earnings
QDEL
Financial Strength
|
Metric
|
QDEL
|
|---|---|
Quick Ratio | 0.65 |
Current Ratio | 1.43 |
Interest Coverage | −5.25 |
Quick Ratio
QDEL
Profitability
|
Metric
|
QDEL
|
|---|---|
Return on Assets (Normalized) | −4.41% |
Return on Equity (Normalized) | −11.38% |
Return on Invested Capital (Normalized) | −2.28% |
Return on Assets
QDEL
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Pmglhqqj | Prplry | $155B | |||
| Stryker Corp
SYK
| Txrpkmbvw | Bykrm | $118B | |||
| Medtronic PLC
MDT
| Dycdmdhky | Ppccmw | $103B | |||
| Boston Scientific Corp
BSX
| Smlhrlfj | Gyqhtb | $70B | |||
| Edwards Lifesciences Corp
EW
| Vzpvkffz | Ptcqn | $49B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Fhcwgypb | Gjqc | $30B | |||
| DexCom Inc
DXCM
| Vfkrxdnpy | Wkttzk | $29B | |||
| Koninklijke Philips NV ADR
PHG
| Zzn | Tvykk | $26B | |||
| Steris PLC
STE
| Pjygsyqp | Qtyhwj | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Fgqjkppmt | Ptwwp | $17B |
United States